Extracorporeal shock wave therapy in the treatment of low back pai

Not Applicable

Completed

• Conditions: ow back pain; Low back pain; Musculoskeletal - Other muscular and skeletal disorders; Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation

• Registration Number: ACTRN12618000593235
• Lead Sponsor: Tomasz Halski

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-04-17
• Study Completion: 2018-11-19
• Last Update Posted: 7 January 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Participants with lumbosacral discopathy and chronic pain syndrome with pseudo-radicular radiation without neurological impairment that have never had any prior spinal surgical intervention will be included in the study. The diagnosis of LBP will be based on MRI scans, which allow to clearly show the advancement of degenerative changes at the L5-S1 spine segment (the inclusion criterion was at least the 3rd grade in the Modic classification).

Exclusion Criteria

The exclusion criteria will be: (1) acute and subacute spine pain episodes (up to 6 months), (2) radicular pain syndrome, (3) degenerative changes on other segments of the spine (only initial, uncomplicated radiological changes (i.e., the 1st or the 2nd grade were allowed according to the Modic classification), (4) past fractures within the spine, (5) tumors and hyperplastic changes, (6) spondylolisthesis, (7) rheumatic diseases, (8) cauda equina syndrome, (9) pregnancy in case of women, (10) chronic heart failure and peripheral vascular disease, (11) arrhythmia and implanted pacemaker, (12) implanted metal implants, (13) skin diseases in the area of shock wave treatment, (14) superficial or deep sensory impairment, (15) mental disorders and addictions, (16) cancer, (17) psoriasis and other immunological diseases, (18) infections, (19) antibiotics and any analgesic, anti-inflammatory, or antithrombotic agent, (20) damage of the vestibular system, (21) inflammation of the vestibular neuron or vestibulocochlear nerve disorder, (22) Meniere's disease, (23) dysfunction of the inner ear, and other (24) diseases of the cerebellum, spinal cord, and brainstem.

Study & Design

• Study Type: Interventional
• Study Design: Not specified